£75 off your first month

Wegovy on the NHS

Medically reviewed by

Summary

Wegovy will be available on the NHS as part of a specialist weight management service for individuals with a BMI over 35 and will be accessible at select high street chemists through in-person visits and online consultations in line with NICE guidance.

Wegovy will be prescribed for a maximum of 2 years under the NHS criteria. If someone doesn’t qualify for an NHS prescription, there are other options available, including private purchase.

Can you get Wegovy on the NHS?

The National Institute for Health and Care Excellence (NICE) has drafted guidance recommending Wagovy as a prescription medication to target weight loss. Wegovy will be available on the NHS England for those with a BMI over 35, type 2 diabetes, pre-diabetes, high blood pressure, dyslipidaemia (unbalanced or unhealthy cholesterol levels), obstructive sleep apnoea, and heart disease / cardiovascular disease. Wegovy will only be prescribed for a maximum of 2 years and must be used in conjunction with regular physical activity and a healthy diet (reduced-calorie diet). The medication criteria will differ from a private prescription plan from the NHS, meaning if you don’t qualify for an NHS prescription, there are additional options available. Speak with one of our healthcare professionals.

What if I don’t meet the NHS Criteria? 

If you do meet the NHS criteria, you can purchase it privately, the cost of Wegovy will depend on whether you are purchasing the pens outright, or through a service that offers Wegovy as part of a lifestyle programme.

What are the differences between the different semaglutide brand names?

Novo Nordisk markets injectable semaglutide under two brand names: Ozempic and Wegovy. Ozempic is primarily utilised to manage type 2 diabetes and reduce the risk of major cardiovascular issues in specific patients. On the other hand, Wegovy is specifically designed for chronic weight management and facilitates weight loss efforts.

Further reading about Wegovy